We understand that Simethicone reduces the surface tension of air bubbles in the tube digestive system, facilitating its dispersion and elimination, and relieving secondary symptoms of excess gas in the gastrointestinal tract. Although simethicone is widely used, the primary application form in the US is in gelcap or liquid. These doses are not the most convenient for consumers. Azelis’ Lab team and expert chemists approached the dilemma with a new lens and identified the need for tablet forms, higher dosages, reduced processing, and costs.

Formulators Benefits

  • Time with high-speed compression thanks to its excellent rheological properties
  • Costs through material and production

  • Stability in final formulation increasing shelf life
  • Patient adoption, with suitablity for all ages* 

*Ages 6+

  • Excipients needed and the manufacturing process
  • Tablet weight while increasing dosage
  • Waste with the right solution galenIQ™ 721

The Right Solution in One Product

The carrier substance of the product is galenIQ™ 721, an isomalt for direct compression, ideal for active ingredients with low compressibility, and improves sweetness in chewable tablets. This solution allows for the reduction of compression force and improves hardness, while simultaneously improving the organoleptics such as sweetness and pleasant chew profile. With the addition of galenIQ™ 721 we have achieved a simplified ingredient list, increased dosage, and a more pleasurable end product to consume.

Samples of the finished formula, the ingredients provided by Azelis, and pricing are all available upon request.

Contact

  • This field is for validation purposes and should be left unchanged.